Dendrite Launches Mobile Operating Environment for Pharmaceutical Sales Force Effectiveness; Wireless Operating Environment Ena

Dendrite International, Inc., (NASDAQ:DRTE) a leading
provider of pharmaceutical industry solutions, today announced the
launch of j-ForceWIRELESS(TM), the first wireless operating
environment designed to provide pharmaceutical sales forces in
developing countries with a turnkey sales force effectiveness
solution. The solution will be introduced in China, one of the fastest
growing pharmaceutical markets in the world, in July, 2006.
   "While the US market continues to see the personal computer as the
central tool for business applications, developing nations are far
more inclined to rely on mobile devices," said Dendrite Chairman and
CEO John Bailye. "With the release of this solution, we are bringing
many of the capabilities to emerging nations that U.S. sales forces
take for granted. This release provides pharmaceutical companies the
ability to maximize productivity of their sales forces."
   j-ForceWIRELESS rests on a secure, proprietary server, and is
simply downloaded by the sales representative onto any web-enabled
handset. Since the application is used in an off-line mode, the
representative is neither dependent on continuous wireless coverage
nor susceptible to escalating data charges. Using the solution, sales
representatives can record daily activities to their mobile phones,
exchange data with the head office for direction or reporting, and
issue alerts.
   "Dendrite has already deployed PDA and Smartphone based solutions
in emerging markets, however, j-ForceWIRELESS takes our
mobile-computing initiatives to next level," said Jean-Paul Modde,
president Dendrite Asia Pacific. "It compliments our current solution
suite and provides the ultimate flexibility in achieving sales force
effectiveness. We are committed to continuously developing innovative
and value-add solutions for the fastest growing economy in the world."

   About Dendrite

   Founded in 1986, Dendrite International (NASDAQ: DRTE) enables
sales, marketing, clinical and compliance solutions for the global,
pharmaceutical industry. The Company's clients are located in more
than 50 countries and include the world's top 20 pharmaceutical
companies. For more information, please visit www.dendrite.com.

   Note: Dendrite is a registered trademark of Dendrite
International, Inc.

   This document may contain forward-looking statements that may be
identified by such forward-looking terminology as "expect," "believe,"
"anticipate," "will," "intend," "plan," "target," "outlook,"
"guidance," and similar statements or variations. Such forward-looking
statements are based on our current expectations, estimates,
assumptions and projections and involve significant risks and
uncertainties, including risks which may result from our dependence on
the pharmaceutical industry; fluctuations in quarterly revenues due to
lengthy sales and implementation cycles for certain of our solutions;
our fixed expenses in relation to fluctuating revenues and variations
in customers' budget cycles; dependence on certain major customers;
changes in demand for our products and services attributable to any
weakness experienced in the economy or mergers, acquisitions and
consolidations in the pharmaceutical industry; successful and timely
development and introduction of new products and versions; rapid
technological changes; increased competition; international
operations; integrating the entities we acquire; our ability to
effectively manage our growth; the protection of our proprietary
technology; our ability to compete in the Internet-related products
and services market; the continued demand for Internet-related
products and services; the ability of our third party vendors to
respond to technological change; our ability to maintain our
relationships with third-party vendors; less favorable than
anticipated results from strategic relationships; dependence of data
solutions on strategic relationships; events which may affect the U.S.
and world economies; and catastrophic events which could negatively
affect our information technology infrastructure. Other important
factors that should be reviewed and carefully considered are included
in the company's 10-K, 10-Qs, and other reports filed with the SEC.
Actual results may differ materially. The company assumes no
obligation for updating any such forward-looking statements to reflect
actual results, changes in assumptions or other changes affecting such
forward-looking statements.